Incidence, risk factors, and outcome of pulmonary invasive fungal disease after respiratory virus infection in allogeneic hematopoietic stem cell transplantation recipients.
José Luis PiñanaMaría Dolores GómezJuan MontoroIgnacio LorenzoAriadna PérezEstela GiménezEva María González-BarberáCarlos CarreteroManuel GuerreiroMiguel SalavertGuillermo SanzJuan Carlos Hernández-BoludaRafael BorrásJaime SanzCarlos SolanoDavide NavarroPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2019)
Allo-HSCT recipients conditioned with ATG and under corticosteroid therapy at the time of CARV LRTD during the first year after transplant may require close monitoring for subsequent IFD.